-
Impact of the Societal Perspective on HTA Decision Making in Rare Diseases
Sep 9, 2025, 16:22 PM -
Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns and Outcomes in First-Line Small-Cell Lung Cancer (SCLC) in France
Sep 9, 2025, 16:22 PM -
Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval
Sep 9, 2025, 16:22 PM -
Development of a Discrete Event Simulation Model to Explore the Potential Cost-Effectiveness for Cancer Early Detection Testing in Female BRCA Carriers
Sep 9, 2025, 16:22 PM -
HPV-Related Disease Burden in Men and Women in the Czech Republic: A Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Identifying Patient-Reported Outcome Measures to Capture Patients’ Experiences of Symptoms and Impacts of Myelodysplastic Syndromes (MDS)
Sep 9, 2025, 16:22 PM -
Are Economic Models in R That Shiny? Making Cost-Effectiveness Models Shinier by Integrating Artificial Intelligence Applications
Sep 9, 2025, 16:22 PM -
An Exploration of Implementing Herd Immunity Into Static Models for Economic Evaluation of Vaccines
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions
Sep 9, 2025, 16:22 PM -
Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA
Sep 9, 2025, 16:22 PM -
Cardioprotective Medication Use Among Diabetic Patients With ASCVD in Qatar's Primary Care Setting
Sep 9, 2025, 16:22 PM -
Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study
Sep 9, 2025, 16:22 PM -
Trends in EMA-Approved New Medicines 2015-2024: New Mechanisms of Action and Regulatory Shifts
Sep 9, 2025, 16:22 PM -
The Impact on Life Expectancy of Delaying or Avoiding Type 1 Diabetes Using the Metabo-Reno-Cardiovascular Disease Model
Sep 9, 2025, 16:22 PM -
Association Between Subjective Sleep Quality and Quality of Life (QoL) Linked With Claims Data in the DeSC Healthcare Database in Japan
Sep 9, 2025, 16:22 PM -
Productivity Impacts and the Need for Carer Support in Obstructive HCM: A Patient and Carer Survey
Sep 9, 2025, 16:22 PM -
Radiographic Progression-Free Survival (rPFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Meta-Analysis and Surrogate Threshold Effect
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of T-DM1 vs. Trastuzumab for Adjuvant Treatment in HER2 Early Breast Cancer (eBC) With Residual Disease in Colombia
Sep 9, 2025, 16:22 PM -
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Rheumatoid Arthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM
